Ali Olyaei

Professor
Send an Email

Office: 503-494-1308

Credentials: 
Pharm.D., University of Kansas, 1990–1991 BS Pharmacy, Oregon State University, 1984–1988

Profile Field Tabs

At OSU
Affiliated with: 
Pharmacy Professnl Instr
Faculty Type: 
Pharmacy Practice
Research/Career Interests: 

Ali Olyaei practices in the area of Nephrology and Transplant Medicine. His research interests include the pharmacokinetics and pharmacodynamic of immunosuppressants. He has served as a research mentor for Transplant and Nephrology Fellows, Pharmacy residents and other faculty engaged in relevant transplant and pharmacotherapy studies conducted on patients with chronic kidney disease.

Selected Publications

Publications/Creative Work:
Textbook                                                      2 Textbooks
Research articles in refereed journal                61 Papers
Invited drug review                                         40 Papers
Research abstract in refereed journal                61 Abstracts
Invited book chapter                                        58 Chapters

Selected Recent Publications:

Olyaei AJ, Bennett WM. Drug dosage in renal failure in Clinical Nephrotixins: Renal Injury from Drugs and Chemicals, 3nd Edition, Eds. DeBroe, Porter, Bennett and Verpooten. Kluwer, Dordrecht, The Netherlands, 2008.

Olyaei AJ, Whelton A, Sturmer T Porter GA, Non-steroidal anti-inflammatory Drugs in Clinical Nephrotixins: Renal Injury from Drugs and Chemicals, 3nd Edition, Eds. DeBroe, Porter, Bennett and Verpooten. Kluwer, Dordrecht, The Netherlands, 2008

Olyaei AJ, Bennett WM: Drug Dosing in Chronic Kidney Disease New York, 2008.

Wahba WI, Olyaei AJ, Rozansky D, Bennett WM .Handling of Drugs in Children with Abnormal Renal Function. Paediatric Nephrology, submitted 2008

Olyaei AJ, Bennett MW. Cardiovascular Disease in Kidney Transplant Recipients: Are Patients Truly Stable? Graft 2005;7:3-1-20

de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, Norman DJ, Becker T. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors.Kidney Internation 2006; Nov;46(6):329-36.

Horn D, Neofytos D, Fishman J, Steinbach W, Anaisie E, Marr KA, Pfaller M, Olyaei A. Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia. Eur J Clin Microbiol Infect Dis. 2007 Sep 25

Olyaei, AJ, Bennett WM. Nephrotoxins in Transplant Recipients. Paediatric Nephrology, submitted 2009.

Olyaei AJ, Roberti G. “Drug Dosing in Chronic Kidney Disease” submitted Hand Book of Chronic kidney disease. 2010

Olyaei AJ. Secret in Nephrology 2010. Drug Used in Dialysis

Suzanne S, Olyaei AJ, and Sica D.  Clinical Pharmacology NephSAP - Nephrology Self Assessment Program.Volume 9, Number 4, July 2010.

Olyaei AJ, Bennett MW Drug Dosing In Older Patients with Renal Impairment. Clin Geriatr Med. 2009 Aug;25(3):459-527.

Drug Dosing and Renal Toxicity in the Elderly Patient; Olyaei AJ, Bennett MW, Introduction to the American Society of Nephrology Geriatric Nephrology Curriculum, 2010

Jagdeep Obhrai,  Jordana Gaumond, Anuja Mittalhenkle, Ali Olyaei, “Management practices for general nephrologists in the care of renal transplant recipients” CJASN 2010; Clin J Am Soc Nephrol. 2010 Jun 24.

History

Member for
3 years 6 months